Urologix to Host Its Fiscal 2010 Third Quarter Conference Call.

MINNEAPOLIS -- Urologix(e), Inc. (Nasdaq:ULGX) will host a conference call to present fiscal 2010 third quarter results on Tuesday, April 27, 2010 at 4:00 p.m. CT, following the Companys post-market press release on the same day. On the day of the call, please dial 1-866-356-4123 and enter the Participant Passcode 74263703 at least 10 minutes prior to the call. The conference call will be broadcast live over the Internet at www.urologix.com. Stryker Warren, Jr., Chief Executive Officer, will host the call.

Webcast listeners should log on at least 10 minutes prior to the scheduled start time of the call to register and download or install any required audio software. A replay of the call will be available until May 4, 2010 at 4:00 p.m. CT (5:00 p.m. ET). To listen to the replay, please dial 1-888-286-8010 and enter the Participant Passcode 66383357.

The webcast is also being distributed over CCBNs Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBNs individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBNs Individual Investor Network. Institutional investors can access the call via CCBNs password-protected event management site, StreetEvents (www.streetevents.com).

About Urologix

Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix products include the CoolWavee, Targise and Prostatrone control units and the CTC Advance, Cooled ThermoCathe , Targise and Prostaprobee catheter families. All of Urologix products utilize Cooled ThermoTherapy- targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort - and provide safe, effective, lasting relief of the symptoms of BPH.